In a laboratory in Sardinia, Italian researchers have discovered that multifloral honey — one of nature's oldest medicines — may carry within it a molecular language that human skin cells already know how to hear. By pretreating cultured skin cells with a dilute honey solution before exposing them to ultraviolet radiation, scientists at the University of Sassari observed something ancient and modern at once: the activation of protective genes, the quieting of aging signals, and a strengthening of the cell's own capacity for renewal. The findings do not yet reach the clinic, but they extend a t
Multifloral honey shows promise in protecting skin cells from UV damage
honey seemed to help cells find a healthier balance after UV stress
Mark
Why multifloral honey specifically? What makes it different from other honeys?
Mimi
The researchers were intrigued by the fact that certain honeys like Manuka already have medical applications. They wanted to test whether a broader, more accessible category of honey—made from many flower sources—could show similar protective effects. It's partly about accessibility, partly about whether the benefits are unique to rare honeys or more widespread.
Mark
So they grew skin cells in a bioreactor. Why not just test honey on actual skin?
Mimi
Cell cultures let you control every variable and measure genetic responses precisely. You can't do that on living skin. But it's also why they're being cautious—what works in a dish doesn't always work in a person. That's the whole reason they're moving toward nanofiber systems and planning human trials.
Mark
The honey reduced aging genes and boosted renewal genes. Does that mean it actually reverses aging?
Mimi
Not quite. It appears to help cells maintain a healthier balance under UV stress. The cells aren't aging as quickly when exposed to the sun, but that's different from reversing damage that's already done. It's more like a shield than a cure.
Mark
What's the practical application here? Is this going into sunscreen?
Mimi
That's the long-term possibility. Right now they're developing nanofiber delivery systems—essentially a way to package honey's active compounds so they can be incorporated into cosmetic or medical formulations. But that's years away from any product you'd buy.
Mark
Why are they being so cautious about claiming this works?
Mimi
Because it doesn't work in humans yet. Everything they've shown is in laboratory conditions. The gap between a cell culture and a clinical trial is enormous. They're being honest about that gap rather than overselling preliminary results.
El Pulso
- UV radiation remains one of the most relentless accelerants of skin aging and cellular damage, and current protections leave significant biological gaps that researchers are racing to fill.
- A one-percent solution of multifloral honey — applied to stem cells, fibroblasts, and keratinocytes in a bioreactor — triggered a cascade of protective genetic activity that untreated cells, left exposed, could not muster.
- The honey appeared to do something unusually precise: it boosted cellular renewal signals while suppressing aging markers, and reduced nitric oxide stress without sending cells into an exhausting over-repair spiral.
- Researchers are now working to confirm these genetic findings at the protein level and are engineering honey-carrying nanofibers designed to deliver its active compounds into living skin tissue in a controlled way.
- No sunscreen should be set aside — this research lives in cell cultures, not human trials, and the road from laboratory signal to clinical standard remains long and carefully gated.
In a laboratory in Sardinia, Italian researchers have discovered that multifloral honey — one of nature's oldest medicines — may carry within it a molecular language that human skin cells already know how to hear. By pretreating cultured skin cells with a dilute honey solution before exposing them to ultraviolet radiation, scientists at the University of Sassari observed something ancient and modern at once: the activation of protective genes, the quieting of aging signals, and a strengthening of the cell's own capacity for renewal. The findings do not yet reach the clinic, but they extend a thread of inquiry that connects beekeeping, cosmetic science, and the long human search for shelter from the sun.
Inside a bioreactor at the University of Sassari in Italy, human skin cells were given an unusual preparation before facing ultraviolet light: a one-percent solution of multifloral honey. What researchers found when they examined those cells afterward has added a quiet but significant entry to the long history of honey in medicine.
Dr. Fikiye Fulya Kavak, guided by Prof. Margherita Maioli and drawing on her own background in medical biology and beekeeping, wanted to know whether honey made from many flower sources could do more than heal wounds — whether it might actively protect skin from the molecular damage that sunlight inflicts. The team cultured three cell types and allowed half of them to bathe in the honey solution for forty-eight hours before UV exposure. Then they measured the difference.
The results pointed toward something real. In stem cells and fibroblasts, honey pretreatment switched on genes associated with cellular renewal and switched off those linked to aging. It reduced nitric oxide — a stress molecule — while strengthening antioxidant defenses. Crucially, it did not trigger an overwhelming repair response; instead, it seemed to help cells find a kind of equilibrium, protective but not exhausted.
The team is now confirming these genetic findings at the protein level and developing nanofiber systems designed to carry honey's active compounds into skin tissue in a biocompatible, controlled way. They are measured in their claims: this is laboratory work, not a clinical recommendation, and sunscreen is not going anywhere yet. But the research offers a credible foundation — evidence that multifloral honey speaks to protective mechanisms already present in human skin cells, and a direction worth following toward whatever comes next.
In a laboratory at the University of Sassari in Italy, researchers have been growing human skin cells in a carefully controlled environment—a bioreactor system designed to mimic the conditions inside living tissue. Before exposing these cells to ultraviolet radiation, they treated some of them with a simple substance: multifloral honey, diluted to one percent. What they found suggests that honey might offer a genuine shield against the cellular damage that UV rays inflict on skin.
Honey has long held a place in medicine. Manuka honey in particular has earned its way into sterile medical products—dressings, gels, ointments for burns and wounds that refuse to heal. The substance carries a reputation for fighting infection, taming inflammation, and spurring tissue repair. But Dr. Fikiye Fulya Kavak, working under Prof. Margherita Maioli's direction, wondered whether a broader category of honey—the multifloral kind, made from many flower sources—might do something more: protect skin cells from the accelerating damage of sun exposure. Kavak's background in medical biology, combined with a personal passion for beekeeping and cosmetic science, made the question feel urgent and personal.
The sun's ultraviolet rays are relentless. They speed up skin aging, stress cells in ways that can lead to cancer, and erode the skin's ability to repair itself. The research team wanted to know not just whether honey could shield cells from this damage, but how—which genes switched on, which switched off, what molecular machinery honey might be engaging.
They cultured three types of skin cells: stem cells, fibroblasts, and keratinocytes. For forty-eight hours before UV exposure, half the cultures bathed in that one-percent honey solution. Then came the stress test. The researchers measured how treated and untreated cells responded, and they sequenced the genetic activity using real-time quantitative PCR to track which genes were expressing themselves in response.
The results were striking. In skin stem cells and fibroblasts, the honey pretreatment appeared to activate a protective response. In stem cells specifically, honey boosted the expression of genes tied to stemness—the cell's capacity to renew itself and differentiate into new tissue. At the same time, it dampened genes associated with aging. The honey also reduced the release of nitric oxide, a molecule that can damage cells under stress, while simultaneously strengthening the cells' antioxidant defenses. The genetic analysis revealed something subtler still: honey seemed to help cells find equilibrium. Rather than triggering an excessive, exhausting repair response, it supported protective mechanisms while keeping renewal signals measured and controlled.
Dr. Kavak and her team are still working through the details. They are now validating their findings at the protein level—confirming that the genetic changes they observed translate into actual changes in the molecules that do the work inside cells. They are also developing a delivery system: nanofibers engineered to carry honey's active compounds into skin tissue in a controlled, biocompatible way. These fibers have been characterized, and their biological evaluation is underway.
But the researchers are careful not to overstate what they have found. This work happened in cell cultures, not in living human skin. No one should abandon sunscreen or expect honey to replace it. The path from laboratory discovery to clinical reality is long and uncertain. What this research does offer is a foundation—evidence that multifloral honey engages real protective mechanisms in human skin cells, and a direction for future work. If those nanofiber systems prove effective, if human trials eventually confirm what the cells suggest, then honey might one day become part of a new generation of skin-protective formulations. For now, it remains a promising signal from the lab, waiting for the world to catch up.
Citas Notables
Rather than pushing the cells into an exaggerated repair response, it appeared to support protective mechanisms while keeping renewal-related signals under control.— Dr. Fikiye Fulya Kavak, University of Sassari
Our study was performed in cell-based experimental models, not in humans, so further laboratory, preclinical, and clinical studies are needed before any practical recommendation can be made.— Dr. Fikiye Fulya Kavak
Quieres la nota completa?
Lee el original en News-Medical ↗
Health & Medicine